Companies: 10,795·Total market cap: $144.5T
Quipt Home Medical Corp.

Quipt Home Medical Corp.

QIPTNASDAQHealthcare
$3.65
+$0.00(+0.00%)
Market Cap$162297148
P/E Ratio
52W High$3.65
52W Low$1.35

Quipt Home Medical Corp.(QIPT)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

qipt · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年5月10日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$3.65

Consensus

$3.65

+0.0% upside

Low

$3.65

Median: $3.65 · Last Close: $3.65

Quipt Home Medical Corp.(QIPT)的分析师共识为 Buy,基于过去 3 个月内 2 位华尔街分析师的评级。QIPT 的 12 个月平均目标价为 $3.65,相对当前价 $3.65 代表 +0.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.650.02%

1-day model range: $3.65–$3.65. Peak: $3.65 (+0.02%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

86%14%0%
12Buy
2Neutral
0Sell
RSI (14)66.7Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · QIPT · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.65NEUTRAL
MA 10$3.65BUY
MA 20$3.64BUY
MA 50$3.60BUY
MA 100$3.19BUY
MA 200$2.74BUY
Current $QIPT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.65BUY
EMA 10$3.65BUY
EMA 20$3.63BUY
EMA 50$3.53BUY
EMA 100$3.27BUY
EMA 200$2.75BUY
Current $QIPT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Canaccord Genuity2025-12-17
Maintains
HoldHold
Canaccord Genuity2025-08-19
Maintains
HoldHold
Benchmark2025-05-14
Maintains
BuyBuy
Canaccord Genuity2025-05-13
Downgrade ↓
BuyHold
Benchmark2024-08-21
Maintains
BuyBuy
Canaccord Genuity2024-08-16
Maintains
BuyBuy
Benchmark2024-05-20
Maintains
BuyBuy
Canaccord Genuity2024-05-17
Maintains
BuyBuy
Benchmark2021-12-31
Maintains
BuyBuy
Benchmark2021-10-20
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Quipt Home Medical Corp. (QIPT) stock. Of the recent 10 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover QIPT.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

QIPT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$258M

↓ 15.5% YoY

Revenue Next Year

$239M

↓ 7.3% YoY

EPS This Year

$-0.09

EPS Next Year

$-0.20

↑ 128.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast QIPT EPS of $-0.09 for the current fiscal year, based on estimates from 2 analysts. The QIPT revenue forecast is $258M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

QIPT 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。QIPT 的共识目标价为 $3.65(+0.0% 上行空间),分析师共识为 Buy。

QIPT 的短期预测(明日)为 $3.65(+0.02%)。

Quipt Home Medical Corp. 在 NASDAQ 上市,代码 QIPT。QIPT 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

QIPT 预测 · 8 个问题

根据 2 位华尔街分析师,QIPT 的 12 个月平均目标价为 $3.65,最高 $3.65、最低 $3.65。若有图表,中位目标价可在上方查看。相对当前价 $3.65,隐含约 +0.0% 的上行空间。

QIPT 目标价QIPT 分析师目标价QIPT 12个月目标价目标价 QIPT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.